Kerala Bans Sresan Medicines After TN Cancels Licence, Halts Substandard Respifresh TR
The move is a precaution to protect children pending laboratory findings.
Overview
- Health Minister Veena George announced a statewide ban on the distribution and sale of all medicines manufactured by Tamil Nadu-based Sresan Pharmaceuticals.
- The ban follows the Tamil Nadu Drugs Controller’s cancellation of Sresan’s manufacturing licence.
- Kerala also halted distribution of Respifresh TR syrup (60 ml, Batch R01GL2523) after Gujarat regulators found it substandard, directing five Kerala suppliers to stop sales.
- Officials advised the public not to use the flagged medicines, clarified they are not supplied through government hospitals, and warned of strict action against sellers.
- The Health Department asked for notices to pharmacies not to dispense pediatric drugs without a doctor’s prescription and formed a committee to review pediatric cough syrup management following reported child deaths in Chhindwara that remain under investigation.